![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 47, 36506-36508, November 24, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Chemistry and Chemical Biology, Harvard
University, Cambridge, Massachusetts 02138
Cytosine deamination and the misincorporation of
2'-dUrd into DNA during replication result in the presence of
uracil in DNA. Uracil-DNA glycosylases (UDGs) initiate the excision
repair of this aberrant base by catalyzing the hydrolysis of the
N-glycosidic bond. UDGs are expressed by nearly all
known organisms, including some viruses, in which the functional role
of the UDG protein remains unresolved. This issue could in principle be
addressed by the availability of designed synthetic inhibitors that
target the viral UDG without affecting the endogenous human UDG. Here, we report that double-stranded and single-stranded oligonucleotides incorporating either of two dUrd analogs tightly bind and inhibit the
activity of herpes simplex virus type-1 (HSV-1) UDG. Both inhibitors
are exquisitely specific for the HSV-1 UDG over the human UDG. These
inhibitors should prove useful in structural studies aimed at
understanding substrate recognition and catalysis by UDGs, as well as
in elucidating the biologic role of UDGs in the life cycle of herpesviruses.
ACCELERATED PUBLICATION
Selective Inhibition of Herpes Simplex Virus Type-1 Uracil-DNA
Glycosylase by Designed Substrate Analogs*,
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The on-line version of this article (available at
http://www.jbc.org) contains Figs. S1 and S2.
To whom correspondence should be addressed: Dept. of Chemistry and
Chemical Biology, Harvard University, 12 Oxford St., Cambridge, MA
02138. Tel.: 617-495-5323; Fax: 617-495-8755; E-mail:
verdine@chemistry.harvard.edu.
This article has been cited by other articles:
![]() |
G. Serrano-Heras, J. A. Ruiz-Maso, G. d. Solar, M. Espinosa, A. Bravo, and M. Salas Protein p56 from the Bacillus subtilis phage {phi}29 inhibits DNA-binding ability of uracil-DNA glycosylase Nucleic Acids Res., August 13, 2007; (2007) gkm584v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Krusong, E. P. Carpenter, S. R. W. Bellamy, R. Savva, and G. S. Baldwin A Comparative Study of Uracil-DNA Glycosylases from Human and Herpes Simplex Virus Type 1 J. Biol. Chem., February 24, 2006; 281(8): 4983 - 4992. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. L. Jiang, A. C. Drohat, Y. Ichikawa, and J. T. Stivers Probing the Limits of Electrostatic Catalysis by Uracil DNA Glycosylase Using Transition State Mimicry and Mutagenesis J. Biol. Chem., May 3, 2002; 277(18): 15385 - 15392. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |